InvestorsHub Logo
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

Re: kfcyahoo post# 25338

Tuesday, 03/21/2017 9:10:39 PM

Tuesday, March 21, 2017 9:10:39 PM

Post# of 38634

"This action is another example of the strategic evolution of our portfolio, and will free resources for investing in our growth platforms in autoimmune and rare diseases and hospital therapies," said Mark Trudeau, President and Chief Executive Officer of Mallinckrodt. "Our Intrathecal Therapy business is an excellent fit for Piramal Critical Care, and is the best solution to meet patient needs




When it was vasogen weren't they working on various autoimmune disease treatments? Kind of reaching but maybe they plan to buy out that tech from ipci which would give them the capital to pay off that loan and go forward.

Again kind of speculating with no real basis but interesting
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News